InvestorsHub Logo
Followers 884
Posts 80769
Boards Moderated 2
Alias Born 01/09/2006

Re: None

Thursday, 04/02/2020 9:56:49 AM

Thursday, April 02, 2020 9:56:49 AM

Post# of 821321
$EDXC 2 more days till #NASDAQ interview, record Q2 numbers:

https://stockcharts.com/c-sc/sc?s=EDXC&p=D&yr=0&mn=6&dy=0&i=t5004181483c&r=1585835381430

https://finance.yahoo.com/news/cbd-unlimited-updates-stakeholders-interview-093010473.html

CBD Unlimited Updates Stakeholders in Interview Via Remote Location at Nasdaq MarketSite
GlobeNewswire GlobeNewswireMarch 31, 2020
Company’s CEO, Todd Davis, discusses second quarter activity

CAVE CREEK, AZ, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, announced today that the Company was interviewed by reporter Jane King to discuss key activities and updates for its fiscal second quarter.

The update interview will be available on April 6, 2020.

CBD Unlimited’s CEO and Chairman, Todd Davis, had an interview on Friday, March 20, as Nasdaq and Wall Street were going into Coronavirus 19 lockdown mode.

Mr. Davis commented that “updating shareholders is critical in these times of uncertainty. CBD Unlimited has set new records in the quarter ending March 31, in spite of a challenging environment, and has accelerated its growth initiatives going forward for the second half of the fiscal year and into 2021.”

About CBD Unlimited, Inc.

CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.

In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.

Website: www.cbdunlimited.com

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.

Contact:

For further investor and media information, contact:

CBD Unlimited, Inc.

Todd Davis

Chairman & CEO

Todd@cbdunlimited.com

480-595-6900

Buy it, trade it, hold it, ignore it... do whatever your want, just
don't do it because of what I say as my posts are just my opinion.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.